According to the World Health Organization, one of the biggest health threats around the world is antibiotic-resistant bacteria. Researchers at Notre Dame are working to combat this problem by developing a nanoparticle-based system. Please check out this press release written by Brandi Wampler, our science communication specialist at Notre Dame Research. https://news.nd.edu/news/new-technology-could-help-tackle-antibiotic-resistance/ The peer-reviewed publication …
Tag Archive: #biomimetic
Recent Posts
- Phage-Mimicking Antibacterial Nanoparticles Tackle Group A Streptococcal Infections In Vivo January 29, 2024
- 2nd Annual Berthiaume Institute for Precision Health’s Advisory Board Meeting October 30, 2023
- 1st Place Poster at the Military Health Sciences Research Symposium 2023 (Aug 14-17, Kissimmee, FL) August 14, 2023
- Congratulations to Ms. Johanna Olesk on Defending her MS (Bioengineering) ’23 Thesis July 7, 2023
- Translational Science to Impact Public Health was our Goal at Techconnect 2023 June 17, 2023
Archives
Categories
NIH Funding Opportunities
- Limited Competition: Physician Scientist Transition to Independence in Blood Science Research (R00 - Clinical Trial Optional) March 28, 2024Funding Opportunity RFA-HL-26-001 from the NIH Guide for Grants and Contracts. The purpose of the NHLBI Career Pathway to Independence in Blood Science Award for Physician Scientists (R00) is to increase and maintain a strong cohort of new and talented, NHLBI supported, independent investigators in blood science. This program is designed to facilitate a timely […]
- Notice of Change to Letter of Intent Due Date(s) Information Listed in RFA-AG-24-001, Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed) March 28, 2024Notice NOT-AG-24-014 from the NIH Guide for Grants and Contracts
- Notice of Participation of the Office of Research on Women's Health (ORWH) in PAR-23-102, "Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)" March 28, 2024Notice NOT-OD-24-090 from the NIH Guide for Grants and Contracts
- Interaction between ARVs and Hormones in HIV and Coinfections (R01 Clinical Trial Optional) March 28, 2024Funding Opportunity RFA-AI-24-018 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support research to identify and characterize the interaction between hormone therapy and antiretroviral drugs (ARVs) used for treatment and prevention of HIV and co-infections.
- Limited Interaction Targeted Epidemiology: Epidemiology of Transmission and Treatment of HIV Among People Who Are at Increased Risk for HIV Infection in Latin America (LITE-LA) (UG3/UH3 Clinical Trial Optional) March 28, 2024Funding Opportunity RFA-AI-24-009 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to support investigators who will form large, electronically-generated cohorts in Latin America of HIV-negative men who have sex with men (MSM), transgender women (TGW), people who inject drugs (PWID), and/or female sex-workers and follow […]
- Tools and resources to understand the vascular pathophysiology of in vivo neuroimaging findings in ARIA (U24 - Clinical Trials Not Allowed) March 28, 2024Funding Opportunity RFA-NS-24-034 from the NIH Guide for Grants and Contracts. The purpose of this Alzheimers Disease-Related Dementia (ADRD) initiative is to promote the development and distribution of innovative technologies, methods, protocols, and biomedical materials that enhance combined human neuropathology and neuroimaging research with data aimed at understanding the underlying pathophysiology of in vivo imaging […]
- NIDDK Central Repository Policy Notice March 28, 2024Notice NOT-DK-24-003 from the NIH Guide for Grants and Contracts
- Notice of ODS and ONR Participation in (RFA-OD-24-009) Data Coordinating and Operations Center for the ECHO IDeA States Pediatric Clinical Trials Network - 3 (U24 Clinical Trial RequiredInfrastructure) March 28, 2024Notice NOT-OD-24-092 from the NIH Guide for Grants and Contracts
- Notice of ODS and ONR Participation in RFA-OD-24-008, Clinical Sites for the Environmental influences on Child Health Outcomes (ECHO) IDeA States Pediatric Clinical Trials Network - 3 (UG1 Clinical Trial Required) March 28, 2024Notice NOT-OD-24-091 from the NIH Guide for Grants and Contracts
- Maximizing Access to Research Careers (MARC) (T34) March 28, 2024Funding Opportunity PAR-24-138 from the NIH Guide for Grants and Contracts. The goal of the Maximizing Access to Research Careers (MARC) program is to: Strengthen research training environments, and Promote broader participation in the biomedical research workforce by expanding the pool of well-trained scientists (for example, encouraging the inclusion of individuals from underrepresented groups) who: […]
Recent Comments